Skip to main content

Published locations for Investigational lupus drug cenerimod moves to phase 3 studies after equivocal phase 2 results

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Investigational lupus drug cenerimod moves to phase 3 studies after equivocal phase 2 results

User login

  • Reset your password
  • /content/investigational-lupus-drug-cenerimod-moves-phase-3-studies-after-equivocal-phase-2-results
  • /edermatologynews/article/263222/lupus-connective-tissue-diseases/investigational-lupus-drug
  • /fedprac/article/263222/lupus-connective-tissue-diseases/investigational-lupus-drug-cenerimod-moves
  • /rheumatologynews/article/263222/lupus-connective-tissue-diseases/investigational-lupus-drug
  • /rheumatology/article/263222/lupus-connective-tissue-diseases/investigational-lupus-drug-cenerimod
  • /dermatology/article/263222/lupus-connective-tissue-diseases/investigational-lupus-drug-cenerimod